SIILPCV10

Drug Profile

SIILPCV10

Alternative Names: 10-valent pneumococcal conjugate vaccine - Serum Institute of India; 10-valent pneumococcal vaccine conjugate - Serum Institute of India; Pneumococcal 10-valent vaccine conjugate - Serum Institute of India; Pneumosil

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PATH; Serum Institute of India
  • Class Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Pneumococcal infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Pneumococcal-infections(Prevention, In adults) in India (IM, Injection)
  • 29 Jun 2017 PATH plans a phase III trial for Pneumococcal infection (In volunteers, In infants) in Gambia (NCT03197376)
  • 01 Jan 2015 Phase-I/II clinical trials in Pneumococcal infections (Prevention) in Gambia (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top